Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DURVALUMAB vs ECONAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DURVALUMAB vs ECONAZOLE: Safety Overview

Metric DURVALUMAB ECONAZOLE
Total FAERS Reports 17,142 450
Deaths Reported 5,088 17
Death Rate 29.7% 3.8%
Hospitalizations 5,968 199
Average Patient Age 65.7 yrs 64.6 yrs
% Female Patients 35.1% 65.5%
FDA Approval Date N/A Apr 18, 2018
Manufacturer AstraZeneca Pharmaceuticals LP Bryant Ranch Prepack
Route INTRAVENOUS TOPICAL
Marketing Status Prescription Discontinued